Good Monday morning again. Welcome to Squawk on the Street. I'm Sarah Eithin with Carl Kintan

live from post nine of the New York Stock Exchange. Today, stalemate. Iran reportedly stopping

negotiations with the U.S. and bowing to completely block the strait of Hormuz. We've got the right

guess. We'll break it down with

former Defense Secretary Mark Esper. Plus the rise of the prediction market's hitting a new

monthly volume record of more than 28 billion in May. The president looking to block those state

restrictions of the technology. We'll discuss it with the CEO of Kalshi, who will join us here at the

NYSC. And a potential breakthrough in the treatment of pancreatic cancer.

New data showing an experimental drug from Revolution Medicines has proven broadly effective

against the tough to treat disease, and the company CEO is with us this hour.

Sarah mentioned the Iranian headlines this morning, took the wind out of futures,

and most of the market, S&P's down just a touch, but consumer discretionary down more than 2%.

Materials down 2% energy up almost 2 and a half is going to make it the best day for crude since April 2nd.

All that said, Vicks isn't moving too much to hanging around 16.

Well, you've still got a lot of the AI names higher,

Arm, Data Dog, Micron, all trading up, including Invidia after the company unveiled new chips

built for PCs. Christina Parsonevilles joins us now with the news on NVIDIA. Christina.

Yeah, InVita and Microsoft are actually teaming up to take on Intel, AMD, and Qualcomm,

specifically in the PC market.

At his keynote last night at Computex in Taipei, Jensen Wong unveiled the RTX Spark, which is

Nvidia's first processor for Windows PC. They're calling it the super chip, but it pairs a new custom

arm-based gray CPU. That's why arm shares are up with a Blackwell GPU designed for

...